ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into 81 Billion Market with AI Technology
IPA Stock | USD 0.41 0.03 7.89% |
About 55% of Immunoprecise Antibodies' investors are presently thinking to get in. The analysis of overall sentiment of trading Immunoprecise Antibodies stock suggests that some investors are interested at this time. The current market sentiment, together with Immunoprecise Antibodies' historical and current headlines, can help investors time the market. In addition, many technical investors use Immunoprecise Antibodies stock news signals to limit their universe of possible portfolio assets.
Immunoprecise |
ImmunoPrecise Antibodies Ltd.
Read at businesswire.com
Immunoprecise Antibodies Fundamental Analysis
We analyze Immunoprecise Antibodies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunoprecise Antibodies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunoprecise Antibodies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Immunoprecise Antibodies is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Immunoprecise Antibodies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunoprecise Antibodies stock to make a market-neutral strategy. Peer analysis of Immunoprecise Antibodies could also be used in its relative valuation, which is a method of valuing Immunoprecise Antibodies by comparing valuation metrics with similar companies.
Peers
Immunoprecise Antibodies Related Equities
STTK | Shattuck Labs | 6.93 | ||||
IPSC | Century Therapeutics | 3.85 | ||||
ANNX | Annexon | 3.73 | ||||
CSBR | Champions Oncology | 3.59 | ||||
INAB | In8bio | 3.33 | ||||
CUE | Cue Biopharma | 2.83 | ||||
TCRX | Tscan Therapeutics | 2.65 | ||||
UBX | Unity Biotechnology | 1.68 | ||||
AVTE | Aerovate Therapeutics | 0.75 | ||||
EXAI | Exscientia | 0.00 | ||||
WVE | Wave Life | 0.40 | ||||
ELYM | Eliem Therapeutics | 1.32 | ||||
ZURA | Zura Bio | 1.63 | ||||
RXRX | Recursion Pharmaceuticals | 1.83 | ||||
CGTX | Cognition Therapeutics | 2.44 | ||||
AVIR | Atea Pharmaceuticals | 2.94 | ||||
ANEB | Anebulo Pharmaceuticals | 4.11 | ||||
DRMA | Dermata Therapeutics | 4.35 | ||||
TFFP | Tff Pharmaceuticals | 6.25 |
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
CEOs Directory Screen CEOs from public companies around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |